Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity

BACKGROUND: To validate an artificial neural network (ANN) based on the combination of PSA velocity (PSAV) with a %free PSA-based ANN to enhance the discrimination between prostate cancer (PCa) and benign prostate hyperplasia (BPH). METHODS: The study comprised 199 patients with PCa (n = 49) or BPH...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephan, Carsten, Büker, Nicola, Cammann, Henning, Meyer, Hellmuth-Alexander, Lein, Michael, Jung, Klaus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543033/
https://www.ncbi.nlm.nih.gov/pubmed/18764937
http://dx.doi.org/10.1186/1471-2490-8-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543033/
https://www.ncbi.nlm.nih.gov/pubmed/18764937
http://dx.doi.org/10.1186/1471-2490-8-10

Ejemplares similares